Phase II trial of amoxicillin/omeprazole/rifabutin [RHB 105] in patients with Helicobacter pylori infection.
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2015
At a glance
- Drugs Amoxicillin/omeprazole/rifabutin (Primary)
- Indications Helicobacter pylori infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors RedHill Biopharma
- 29 Apr 2015 New trial record
- 27 Apr 2015 Positive results published in a RedHill Biopharma media release.